Hadassah Study Suggests Cancer Treatment for Kidney is Effective for Sarcoma Too
Dr. Daniela Katz
A recent study headed by Dr. Daniela Katz, Sarcoma Unit Coordinator at the Hadassah University Medical Center's Sharett Institute of Oncology, suggests that the biological therapy given to patients with kidney cancer is also effective for patients with sarcoma, a bone and soft tissue cancer.
The therapy is an oral medication called Pazopanib. When given to adults with advanced kidney cancer, the evidence indicates a statistically significant improvement in retarding tumor progression. Hadassah Hospital-Ein Kerem's Department of Oncology is now offering the treatment free of charge to sarcoma patients with advanced or metastatic disease.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>